4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-005463
Options or other derivatives
- Chief Scientific Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Russell Alan J · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +120,000 | 120,000 | D |
Loading xslF345X03/primarydocument.xml…